Mölnlycke Health Care - A world leading MedTech company
Transforming care for patients and caregivers
At Mölnlycke, we have always been dedicated to improving quality of life for patients and those who care for them. We do it by offering innovative, high-quality solutions for wound care and surgical procedures, and by helping you implement new, better ways of working. Ultimately, we enable safer, more efficient and more sustainable care. For people and planet.
-
Wound care solutions
Explore our offer of innovative solutions that are optimised for health care workflows while improving quality of care for patients.
Discover our wound care solutions -
Surgical solutions
A safe and stress-free care environment, where clinicians can perform at their very best, doing the job they care most about.
Discover our surgical solutions
Get in touch
We're here to help
If you have any question about our products and solutions or need assistans, contact our sales team. We look forward to helping you find the perfect solution for your needs.
Contact usLatest updates
Discover our latest offers and campaigns.
Hibiwash® replaces Hibiscrub®
Hibiwash® has the same active ingredients, IFU, indications, and efficacy as Hibiscrub.
Learn moreLatest news
Read all news-
Mölnlycke Health Care strengthens global manufacturing footprint to power future growth in wound care
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
5 million and growing: scaling Granudacyn® production in Salzburg
-
First factory in China reaches key milestone and strengthens Mölnlycke’s global manufacturing network
Mölnlycke has completed construction of its first manufacturing facility in China, marking a major milestone in the company's growth journey and strengthening its ability to serve one of the world's largest and fastest growing healthcare markets.
-
Mölnlycke Health Care and Zhende Medical form pioneering joint venture to expand access to advanced wound care solutions in China
Gothenburg, Sweden, and Shanghai, China. 21 May 2026.
Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech and advanced wound care solutions, and Zhende Medical, a leading supplier of medical care and protection in China, today announce the formation of a new joint venture company in China to accelerate growth in one of the world’s fastest-growing wound care markets. The joint venture, majority-owned by Mölnlycke, will integrate the two companies’ wound care portfolios and commercial capabilities to offer healthcare providers, patients and the public expanded access to advanced treatments, improved care delivery and better patient outcomes across China. -
Simple glove change could save the NHS £45 million over five years and improve caesarean safety
Gothenburg, Sweden. 27 April 2026. A new study1 published in the Journal of Hospital Infection shows that introducing a simple glove change during caesarean birth could deliver millions in cost savings for the National Health Service (NHS) in England.
-
Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
-
Mölnlycke Health Care annual report 2025 highlights sustainable growth and strategic transformation
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.
-
Europe faces a growing chronic wound crisis – time to act is now
Gothenburg, Sweden. 31 March 2026. Mölnlycke®, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry white paper from the MedTech Europe Wound Care Sector Working Group. The wound paper highlights the growing burden of chronic wounds and urges EU policymakers to elevate wound care as a strategic health priority across the EU.
Upcoming events
See all events-
Webinar - Trojan Horse in Plain Sight: the Nasal Microbiome and HCAIs
-
Infection Prevention & Control Conference 2026
-
Join us at EWMA 2026, 6-8 May
-
Stopping infections at source: Exploring the characteristics of effective nasal and skin decontamination
-
Join Mölnlycke at the World Union of Wound Healing Societies (WUWHS) Congress 2026
Knowledge
See all articles-
Wound care | 1 min read What can I do to support my venous leg ulcer?
While your nurse or doctor helps you with the right treatment plan for your venous leg ulcer, the choices you make every day at home can support healing. Small, consistent actions and daily choices to help your leg ulcer healing at home will improve your health and wellbeing. Maintaining healthy habits, such as eating and drinking well and staying active, can help reduce the risk of your venous leg ulcer recurring after it has healed.
-
Wound care | 1 min read Signs of an infected venous leg ulcer
What is a venous leg ulcer? A venous leg ulcer is an open wound on your lower leg or ancle that hasn't healed after two weeks. It can happen if veins in the legs are weakened. Our veins carry blood back to the heart, with the help of small valves to keep it flowing in the right direction.
-
Wound care | 1 min read Why compression therapy is important
You may be wondering why you need compression therapy. Compression therapy is a key phase for venous leg ulcer treatment because it improves blood flow, reduces swelling, and helps the ulcer to heal. Wearing your compression therapy as advised by your doctor or nurse can also help reduce the risk of ulcers returning.
-
Antiseptics | 1 min read Webinar - Trojan Horse in Plain Sight: the Nasal Microbiome and HCAIs
Despite sustained investment in surface cleaning, hand hygiene and personal protective equipment, healthcare-associated infections (HCAIs) remain a persistent challenge globally. Increasing evidence suggests that endogenous microbial reservoirs - particularly the nasal microbiome - act as a “Trojan horse”, quietly harbouring pathogens that can seed infections and undermine prevention efforts from within.
-
Surgical | 6 min read Find your most efficient OR flow
-
Wound care | 2 min read Support your healing by making the right choices
-
Wound care | 4 min read Addressing skin tone bias in wound assessment
The Skin Tone I.D.TM by Mölnlycke® supports accurate skin assessment
-
Wound care | 2 min read Managing exudate, making laboratory testings clinically relevant
An article from the International Wound Journal highlights the critical role of utilising data from clinically relevant laboratory tests and well-structured clinical studies in the dressing selection process.
-
Surgical | 3 min read Laparoscopic surgery recovery and post-laparoscopic care
Patients, healthcare professionals and hospital administrators alike see benefits of the laparoscopic surgery healing process.